Polymorphisms of rs12979860, rs8099917 and rs368234815, two SNPs upstream of the IL28B coding region and one upstream of IFNL4 coding region, are characteristic host factors that predict responses of CHC patients to IFN treatment [9–13,28,29]. This evidence concerns the gene IFNL3 and cryohydrocytosis.